These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Singh VK, Kalra HK, Yamaki K, Shinohara T. Cell Immunol; 1992 Jan; 139(1):81-90. PubMed ID: 1728971 [Abstract] [Full Text] [Related]
7. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Vrabec TR, Gregerson DS, Dua HS, Donoso LA. Autoimmunity; 1992 Jan; 12(3):175-84. PubMed ID: 1343765 [Abstract] [Full Text] [Related]
8. Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Gregerson DS, Merryman CF, Obritsch WF, Donoso LA. Cell Immunol; 1990 Jun; 128(1):209-19. PubMed ID: 2344622 [Abstract] [Full Text] [Related]
9. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats. Eto K, Suzuki S, Singh VK, Shinohara T. Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112 [Abstract] [Full Text] [Related]
10. Effects of cyclosporin A on the induction of oral tolerance. Fukushima A, Whitcup SM, Nussenblatt RB, Gery I. Ann N Y Acad Sci; 1996 Feb 13; 778():376-8. PubMed ID: 8610995 [No Abstract] [Full Text] [Related]
11. Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. Nussenblatt RB, Whitcup SM, de Smet MD, Caspi RR, Kozhich AT, Weiner HL, Vistica B, Gery I. Ann N Y Acad Sci; 1996 Feb 13; 778():325-37. PubMed ID: 8610986 [Abstract] [Full Text] [Related]
13. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Wildner G, Thurau SR. Eur J Immunol; 1994 Nov 13; 24(11):2579-85. PubMed ID: 7957552 [Abstract] [Full Text] [Related]
14. Labrafil--a new adjuvant for peptide-specific oral tolerance in rat experimental autoimmune uveitis. Diedrichs-Möhring M, Thurau SR, Wildner G. Pharmacol Res; 2008 Jan 13; 57(1):26-31. PubMed ID: 18042397 [Abstract] [Full Text] [Related]
15. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization]. Misiuk-Hojło M, Ruiz-Moreno J, Thillaye B, de Kozak Y. Klin Oczna; 1993 Jan 13; 95(3-4):101-4. PubMed ID: 8377430 [Abstract] [Full Text] [Related]
16. Structure-function studies of S-antigen: use of proteases to reveal a dominant uveitogenic site. Dua HS, Hossain P, Brown PA, McKinnon A, Forrester JV, Gregerson DS, Donoso LA. Autoimmunity; 1991 Jan 13; 10(2):153-63. PubMed ID: 1723632 [Abstract] [Full Text] [Related]
17. Ocular injection of retinal S antigen: suppression of autoimmune uveitis. Mizuno K, Clark AF, Streilein JW. Invest Ophthalmol Vis Sci; 1989 Apr 13; 30(4):772-4. PubMed ID: 2784789 [Abstract] [Full Text] [Related]
18. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats. Sunil S, Eto K, Singh VK, Shinohara T. Cell Immunol; 1993 Apr 15; 148(1):198-207. PubMed ID: 8495487 [Abstract] [Full Text] [Related]
19. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen. Singh VK, Anand R, Sharma K, Agarwal SS. Cell Immunol; 1996 Sep 15; 172(2):158-62. PubMed ID: 8964076 [Abstract] [Full Text] [Related]
20. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein. Roberts AJ, Kasp E, Stanford M, Dumonde DC, Banga JP. Eur J Immunol; 1992 Apr 15; 22(4):951-6. PubMed ID: 1551407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]